ArticleArchives of osteoporosis2025
Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study.
Takaki Yoshiyama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.